8-K: Movano Health Announces 1-for-15 Reverse Stock Split to Regain Nasdaq Compliance

Movano Health will implement a 1-for-15 reverse stock split effective October 29, 2024, to increase its stock price and regain compliance with Nasdaq's minimum bid price requirement.

Summary

• Movano Health has announced a 1-for-15 reverse stock split of its common stock.
• The reverse stock split will be effective at 12:01 a.m. Eastern time on October 29, 2024.
• Trading on a split-adjusted basis will begin when the market opens on October 29, 2024.
• The company's stock will continue to trade on the Nasdaq Capital Market under the symbol MOVE.
• The new CUSIP number for the common stock will be 62459M 206.
• The primary goal of the reverse stock split is to increase the stock's bid price to meet Nasdaq's minimum listing requirements.
• The reverse stock split was authorized by stockholders on July 9, 2024, with the final ratio determined by the Board of Directors.
• The number of outstanding shares will decrease from approximately 99.5 million to approximately 6.6 million.
• The number of authorized shares will remain unchanged.
• Fractional shares will be rounded up to the next whole share.
• Exercise prices and the number of shares underlying equity plans will be adjusted accordingly.
• The par value of the common stock will not be affected.
• Pacific Stock Transfer Company will act as the exchange agent and will send transaction notices to stockholders holding shares electronically.
• Stockholders holding shares through a broker will have their positions adjusted automatically.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the reverse stock split being a measure to avoid delisting, which is generally a sign of financial distress. While the company is trying to regain compliance, this action is not typically viewed positively by investors.

Positives

• The reverse stock split is intended to help Movano Health regain compliance with Nasdaq's minimum bid price requirement, which is crucial for continued listing.
• The process is designed to be automatic for stockholders, requiring no action from most shareholders.
• Fractional shares will be rounded up to the next whole share, ensuring no loss of value for shareholders.

Negatives

• The reverse stock split is a measure taken to avoid delisting from the Nasdaq, which can be seen as a sign of financial distress.
• The reduction in the number of outstanding shares may not be viewed positively by all investors.

Risks

• The reverse stock split may not be sufficient to maintain compliance with Nasdaq listing requirements if the stock price does not increase.
• The reverse stock split could negatively impact investor sentiment and potentially lead to further stock price declines.
• The company's future performance and ability to generate revenue will be critical to long-term success.

Future Outlook

The company expects the reverse stock split to help regain compliance with Nasdaq's minimum bid price requirement. The company continues to focus on the commercial launch of the Evie Ring and EvieMED Ring, and is working on product development, clinical trials and regulatory initiatives.

Management Comments

• The reverse stock split is intended to increase the bid price of the common stock to enable the Company to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.

Industry Context

Reverse stock splits are often used by companies facing delisting from major exchanges due to low stock prices. This action is not uncommon in the biotech and healthcare sectors, where companies may experience volatility in their stock prices due to the nature of their research and development activities.

Comparison to Industry Standards

• Reverse stock splits are a common strategy for companies facing delisting from exchanges like Nasdaq, similar to actions taken by other small-cap biotech firms struggling with low share prices.
• Companies like Cassava Sciences and Ocugen have also used reverse stock splits to maintain their Nasdaq listings.
• The 1-for-15 ratio is within the typical range for reverse stock splits, which can vary from 1-for-2 to 1-for-30.

Corporate Governance

Stakeholder Impact

• Shareholders will see a reduction in the number of shares they own, but the value of their holdings should remain relatively constant immediately after the split.
• The reverse stock split is intended to help the company maintain its Nasdaq listing, which is important for investor confidence.
• The company's employees may be impacted by the overall financial health of the company.

Next Steps

• The company's common stock will begin trading on a split-adjusted basis on October 29, 2024.
• The company will continue to work on product development and commercialization of its wearable health devices.

Key Dates

Keywords

reverse stock split, Nasdaq compliance, stock price, common stock, share reclassification, Movano Health, MOVE, stockholders